Insider trades
Gollob Jared, Chief Officer of Kymera Therapeutics KYMR, has filed 0 purchases and 31 sales on the open market. Over the past 12 months that comes to a net sale of $9.1M. The latest trade was on 03/04.
Gollob Jared
Chief Medical Officer
- Company
- Kymera Therapeutics KYMR
- First filing
- 23/03/03
- Trades
- 57 trades
- Buys / sales
- 0 / 31
- 12-month net buying
- −$9.1M
- Last trade
- 03/04
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
KYMR | Open-market sale | 03/02–03/04 | 03/04 | 10,508 sh7 trades | $87.24avg. | $916,682.44 | −8.2% |
KYMR | Open-market sale10b5-1 plan | 25/12/08 | 25/12/08 | 49,307 sh6 trades | $88.66avg. | $4,371,768.88 | −31.0% |
KYMR | Open-market sale10b5-1 plan | 25/10/15 | 25/10/15 | 59,576 sh4 trades | $61.42avg. | $3,659,199.44 | −35.1% |
| Open-market sale10b5-1 plan | 25/10/13 | 25/10/14 | 3,114 sh | $60.00 | $186,840 | −2.6% | |
KYMR | Open-market sale | 25/03/03 | 25/03/03 | 5,740 sh2 trades | $30.45avg. | $174,794.35 | −4.6% |
KYMR | Open-market sale10b5-1 plan | 24/07/15–24/07/16 | 24/07/16 | 39,600 sh3 trades | $45.53avg. | $1,803,154.44 | −29.3% |
KYMR | Open-market sale | 24/03/04 | 24/03/04 | 3,344 sh3 trades | $41.85avg. | $139,958.52 | −3.4% |
| Open-market sale10b5-1 plan | 24/02/27 | 24/02/29 | 400 sh | $45.00 | $18,000 | −0.5% | |
KYMR | Open-market sale10b5-1 plan | 24/02/09 | 24/02/09 | 46,137 sh2 trades | $35.50avg. | $1,637,967.03 | −38.2% |
KYMR | Open-market sale | 23/03/02 | 23/03/03 | 1,298 sh2 trades | $31.00avg. | $40,236.68 | −1.7% |